DCK and neoplasm: Deoxycytidine kinase (DCK) is a rate-limiting enzyme in the nucleoside salvage pathway, and phosphorylation of DCK (S74) by ATR has been shown to inhibit its activity64,65, reducing nucleoside availability through the salvage pathway, potentially providing additional problems for the tumour cell to overcome.